SCHEMBL4170964

SCHEMBL4170964

C=C(C)CC(O)(CCC)c1ccc(F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
ESR1 P03372 4/20 0.35
ESR2 Q92731 2/20 0.35
KCNN4 O15554 1/20 0.35
USP2 O75604 1/20 0.34
RAB9A P51151 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
ATM Q13315 1/20 0.34
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
LMNA P02545 2/20 0.33
HTT P42858 2/20 0.33
TRPA1 O75762 1/20 0.33
KMT2A Q03164 1/20 0.33
POLB P06746 1/20 0.33
APEX1 P27695 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19226355 0.85 ALDH1A1 (0.49) ALDH1A1TP53TSHRESR1ESR2
SCHEMBL118551 0.85 KCNN4 (0.34) KCNN4USP2RAB9ACYP3A4CYP2D6
SCHEMBL4160841 0.82 CYP2C19 (0.42) ALDH1A1TP53TSHRKCNN4RAB9A
SCHEMBL19226364 0.75 ALDH1A1 (0.41) ALDH1A1TP53TSHRESR1ESR2
SCHEMBL6202674 0.74 ESR1 (0.46) ALDH1A1TSHRESR1ESR2KCNN4
SCHEMBL6092358 0.73 KCNN4 (0.45) ESR1ESR2KCNN4USP2RAB9A
SCHEMBL22431882 0.72 ALDH1A1 (0.39) ALDH1A1TP53TSHRESR1ESR2
SCHEMBL11055846 0.70 CYP2C19 (0.48) ALDH1A1ESR1ESR2KCNN4CYP3A4
SCHEMBL3997259 0.68 HTR7 (0.44) ALDH1A1ESR1ESR2KCNN4RAB9A
SCHEMBL31545336 0.68 RIPK1 (0.38) ALDH1A1ESR1ESR2KCNN4USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108579-A1 CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 VITAE PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108579-A1 CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD11B2, HSD3B1 ALDH1A1 269/4885TP53 4522/4885TSHR 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.